Recent literature review reveals dearth of data, highlights need for more research.
Modern Retina Fall 2021
Current options, challenges in developing novel therapies.
Options facilitate increased durability for patients with retinal degeneration.
Options facilitate increased durability for patients with retinal degeneration.
Underlying autoimmune disease alters uveitis therapy.
Confronting issues unique to aging may lead to better outcomes.
